Cited by 1,052Chronic Obstructive Pulmonary Disease (COPD) ResearchAsthma and respiratory diseasesSmoking Behavior and Cessation

The DOI matches its Crossref record; 141 of the 142 references it cites were found in a registry or an index.

Mortality in COPD: role of comorbidities

Open access

Sin, D. D., Anthonisen, N. R., Soriano, J. B., Agusti, A. G.·2006·European Respiratory Journal

DOI 10.1183/09031936.00133805

Open this paper in CoChat — free account Open PDF

Abstract

Chronic obstructive pulmonary disease (COPD) represents an increasing burden throughout the world. COPD-related mortality is probably underestimated because of the difficulties associated with identifying the precise cause of death. Respiratory failure is considered the major cause of death in advanced COPD. Comorbidities such as cardiovascular disease and lung cancer are also major causes and, in mild-to-moderate COPD, are the leading causes of mortality. The links between COPD and these conditions are not fully understood. However, a link through the inflammation pathway has been suggested, as persistent low-grade pulmonary and systemic inflammation, both known risk factors for cardiovascular disease and cancer, are present in COPD independent of cigarette smoking. Lung-specific measurements, such as forced expiratory volume in one second (FEV(1)), predict mortality in COPD and in the general population. However, composite tools, such as health-status measurements (e.g. St George's Respiratory Questionnaire) and the BODE index, which incorporates Body mass index, lung function (airflow Obstruction), Dyspnoea and Exercise capacity, predict mortality better than FEV(1) alone. These multidimensional tools may be more valuable because, unlike predictive approaches based on single parameters, they can reflect the range of comorbidities and the complexity of underlying mechanisms associated with COPD. The current paper reviews the role of comorbidities in chronic obstructive pulmonary disease mortality, the putative underlying pathogenic link between chronic obstructive pulmonary disease and comorbid conditions (i.e. inflammation), and the tools used to predict chronic obstructive pulmonary disease mortality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1183/09031936.00133805

Cites

141 of 141 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study
Murray, C. J. L., & López, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
Atherosclerosis
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
Celli, B. R., MacNee, W., Agustí, A. G. N., Anzueto, A. R., Berg, B., Buist, A. S., Calverley, P. M., Chavannes, N. H., Dillard, T. A., Fahy, B. F., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,405
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F. S. F., Utokaparch, S., Woods, R. R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,828

Show all 142 references

Research works printed but not linked: 11

1997, Monaldi Arch Chest Dis, 52, 43
1998, Monaldi Arch Chest Dis, 53, 324
1999, Eur Respir J, 14, 387s
10.1001/jama.1994.03520190043033 · DOI
2000, J Am Geriatr Soc, 48, S91
European Respiratory Society, European Lung Foundation. Loddenkemper R, Gibson GJ, Sibille Y, eds. Lung Health in Europe Facts and Figures. Sheffield, ERSJ, 2003; pp. 34–43
2004, Chest, 125, 134S
1998, Int J Mol Med, 2, 715
2001, Chest, 119, 1294
1995, Oncogene, 11, 999
1978, Scand J Respir Dis, 59, 154

Sorted by citations

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0218pp · Cited by 3,187
Self-citation
Global burden of COPD: risk factors, prevalence, and future trends
Mannino, D. M., & Buist, A. S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61380-4 · Cited by 2,120
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,863
Chronic obstructive pulmonary disease
Decramer, M., Janssens, W., & Miravitlles, M. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60968-9 · Cited by 1,026
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Vogelmeier, C. F., Criner, G. J., Martínez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00214-2017 · Cited by 899
Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019
Safiri, S., Carson‐Chahhoud, K., Noori, M., Nejadghaderi, S. A., Sullman, M. J. M., Heris, J. A., Ansarin, K., Mansournia, M. A., Collins, P. G. S., Kolahi, A., et al. (2022) · BMJ · doi:10.1136/bmj-2021-069679 · Cited by 875
Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis
Alqahtani, J. S., Oyelade, T., Aldhahir, A. M., Alghamdi, S., Almehmadi, M., Alqahtani, A., Quaderi, S. A., Mandal, S., & Hurst, J. R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233147 · Cited by 897
Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2007 Update
O’Donnell, D. E., Aaron, S. D., Bourbeau, J., Hernandez, P., Marciniuk, D. D., Balter, M. S., Ford, G. T., Gervais, A., Goldstein, R. S., Hodder, R., et al. (2007) · Canadian Respiratory Journal · doi:10.1155/2007/830570 · Cited by 693
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report
Vogelmeier, C. F., Criner, G. J., Martínez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · Respirology · doi:10.1111/resp.13012 · Cited by 695
Complex chronic comorbidities of COPD
Fabbri, L. M., Luppi, F., Beghé, B., & Rabe, K. F. (2008) · European Respiratory Journal · doi:10.1183/09031936.00114307 · Cited by 660
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Vogelmeier, C. F., Criner, G. J., Martínez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2017.02.001 · Cited by 764
What prevents people with chronic obstructive pulmonary disease from attending pulmonary rehabilitation? A systematic review
Keating, A., Lee, A., & Holland, A. E. (2011) · Chronic Respiratory Disease · doi:10.1177/1479972310393756 · Cited by 583
Epidemiology of COPD
Rahérison, C., & Girodet, P. (2009) · European Respiratory Review · doi:10.1183/09059180.00003609 · Cited by 566
Long-Term PM2.5 Exposure and Respiratory, Cancer, and Cardiovascular Mortality in Older US Adults
Pun, V. C., Kazemiparkouhi, F., Manjourides, J., & Suh, H. H. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx166 · Cited by 546
Adherence to inhaled therapy, mortality and hospital admission in COPD
Vestbo, J., Anderson, J. A., Calverley, P. M. A., Celli, B., Ferguson, G. T., Jenkins, C., Knobil, K., Willits, L. R., Yates, J. C., & Jones, P. W. (2009) · Thorax · doi:10.1136/thx.2009.113662 · Cited by 516
Increased Risk of Myocardial Infarction and Stroke Following Exacerbation of COPD
Donaldson, G. C., Hurst, J. R., Smith, C. J., Hubbard, R., & Wedzicha, J. A. (2009) · CHEST Journal · doi:10.1378/chest.09-2029 · Cited by 514
Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial
Vestbo, J., Anderson, J. A., Brook, R. D., Calverley, P. M. A., Celli, B. R., Crim, C. C., Martínez, F. J., Yates, J., & Newby, D. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30069-1 · Cited by 489
Comorbidities in Chronic Obstructive Pulmonary Disease
Chatila, W. M., Thomashow, B. M., Minai, O. A., Criner, G. J., & Make, B. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200709-148et · Cited by 491
Mechanistic links between COPD and lung cancer
Houghton, A. M. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3477 · Cited by 428
Epidemiology and clinical impact of major comorbidities in patients with COPD
Smith, M., & Wrobel, J. P. (2014) · International Journal of COPD · doi:10.2147/copd.s49621 · Cited by 427
Extrapulmonary Effects of Chronic Obstructive Pulmonary Disease on Physical Activity
Watz, H., Waschki, B., Boehme, C., Claussen, M., Meyer, T., & MAGNUSSEN, H. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1011oc · Cited by 368
Prediction of the Clinical Course of Chronic Obstructive Pulmonary Disease, Using the New GOLD Classification: A Study of the General Population
Lange, P., Marott, J. L., Vestbo, J., Olsen, K. R., Ingebrigtsen, T. S., Dahl, M., & Nordestgaard, B. G. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201207-1299oc · Cited by 369
Cardiovascular Comorbidity in COPD
Müllerová, H., Agustí, A. G. N., Erqou, S. A., & Mapel, D. W. (2013) · CHEST Journal · doi:10.1378/chest.12-2847 · Cited by 360
Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease
Ling, S. (2009) · International Journal of COPD · doi:10.2147/copd.s5098 · Cited by 349
Defining the relationship between COPD and CVD: what are the implications for clinical practice?
Morgan, A. D., Zakeri, R., & Quint, J. K. (2018) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465817750524 · Cited by 355
Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide
Lai, H., Lin, T., Chen, T.-W., Kuo, Y.-L., Chang, C., Wu, T.-R., Shu, C.-C., Tsai, Y.-H., Swift, S., & Lu, C. (2021) · Gut · doi:10.1136/gutjnl-2020-322599 · Cited by 341
COPD Surveillance—United States, 1999-2011
Ford, E. S., Croft, J. B., Mannino, D. M., Wheaton, A. G., Zhang, X., & Giles, W. H. (2013) · CHEST Journal · doi:10.1378/chest.13-0809 · Cited by 304
Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
Listing, J., Kekow, J., Manger, B., Burmester, G.-R., Pattloch, D., Zink, A., & Strangfeld, A. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204021 · Cited by 295
COPD as a Lung Disease with Systemic Consequences – Clinical Impact, Mechanisms, and Potential for Early Intervention
Decramer, M., Rennard, S. I., Troosters, T., Mapel, D. W., Giardino, N. D., Mannino, D. M., Wouters, E. F. �., Sethi, S., & Cooper, C. B. (2008) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550802237531 · Cited by 296
Chronic obstructive pulmonary disease and comorbidities
Decramer, M., & Janssens, W. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(12)70060-7 · Cited by 300
Predictors of Rehospitalization and Death After a Severe Exacerbation of COPD
McGhan, R. M., Radcliff, T. A., Fish, R., Sutherland, E. R., Welsh, C. H., & Make, B. J. (2007) · CHEST Journal · doi:10.1378/chest.06-3018 · Cited by 284
COPD-related morbidity and mortality after smoking cessation: status of the evidence
Godtfredsen, N. S., Lam, T., Hansel, T., Leon, M. E., Gray, N., Dresler, C. M., Burns, D., Prescott, E., & Vestbo, J. (2008) · European Respiratory Journal · doi:10.1183/09031936.00160007 · Cited by 284
The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008
Schnell, K. M., Weiss, C. O., Lee, T. A., Krishnan, J. A., Leff, B. A., Wolff, J. L., & Boyd, C. M. (2012) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-12-26 · Cited by 275
Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD
Chang, C. L., ROBINSON, S. C., Mills, G., Sullivan, G., Karalus, N., McLachlan, J. D., & Hancox, R. J. (2011) · Thorax · doi:10.1136/thx.2010.155333 · Cited by 264
CT Scan Findings of Emphysema Predict Mortality in COPD
Haruna, A., Muro, S., Nakano, Y., Ohara, T., Hoshino, Y., Ogawa, E., Hirai, T., Niimi, A., Nishimura, K., Chin, K., et al. (2010) · CHEST Journal · doi:10.1378/chest.09-2836 · Cited by 267
The natural history of chronic obstructive pulmonary disease
Mannino, D. M., Watt, G. C. M., Hole, D. J., Gillis, C. R., Hart, C., McConnachie, A., Smith, G. D., Upton, M. N., Hawthorne, V. M., Sin, D. D., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00024605 · Cited by 294
From Current Opinion in Pulmonary Medicine
Blanchette, C. M., Berry, S. R., & Lane, S. J. (2011) · Cited by 261
Mortality in COPD: Causes, Risk Factors, and Prevention
Berry, C. E., & Wise, R. A. (2010) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2010.510160 · Cited by 270
The Relationship Between COPD and Frailty
Marengoni, A., Vetrano, D. L., Manes-Gravina, E., Bernabei, R., Onder, G., & Palmer, K. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.02.014 · Cited by 267
Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care
Roversi, S., Fabbri, L. M., Sin, D. D., Hawkins, N. M., & Agustí, A. G. N. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0690so · Cited by 254
Managing comorbidities in COPD
Tzanakis, Ν., Hillas, G., Perlikos, F., & Tsiligianni, I. (2015) · International Journal of COPD · doi:10.2147/copd.s54473 · Cited by 267
Systemic Manifestations of COPD
Nussbaumer‐Ochsner, Y., & Rabe, K. F. (2011) · CHEST Journal · doi:10.1378/chest.10-1252 · Cited by 249
Comorbidities and Short-term Prognosis in Patients Hospitalized for Acute Exacerbation of COPD
Almagro, P., Cabrera, F. J., Díez‐Manglano, J., Boixeda, R., Ortiz, M. B. A., Murio, C., & Soriano, J. B. (2012) · CHEST Journal · doi:10.1378/chest.11-2413 · Cited by 242
Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty—a BOLD analysis
Burney, P., Jithoo, A., Kato, B. S., Janson, C., Mannino, D. M., Niżankowska‐Mogilnicka, E., Studnicka, M., Tan, W. C., Bateman, E. D., Kocabaş, A., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-204460 · Cited by 244
Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management
Woodruff, P. G., Agustí, A. G. N., Roche, N., Singh, D., & Martínez, F. J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60693-6 · Cited by 239
Prevalence of underlying diseases in died cases of COVID-19: A systematic review and meta-analysis
Javanmardi, F., Keshavarzi, A., Akbari, A., Emami, A., & Pirbonyeh, N. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241265 · Cited by 236
Comorbidities, Patient Knowledge, and Disease Management in a National Sample of Patients with COPD
Barr, R. G., Celli, B. R., Mannino, D. M., Petty, T. L., Rennard, S. I., Sciurba, F. C., Stoller, J. K., Thomashow, B. M., & Turino, G. M. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.042 · Cited by 223
Quantitative Assessment of Erector Spinae Muscles in Patients with Chronic Obstructive Pulmonary Disease. Novel Chest Computed Tomography–Derived Index for Prognosis
Tanimura, K., Satô, S., Fuseya, Y., Hasegawa, K., Uemasu, K., Sato, A., Oguma, T., Hirai, T., Mishima, M., & Muro, S. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201507-446oc · Cited by 229
Once-daily indacaterolversustwice-daily salmeterol for COPD: a placebo-controlled comparison
Kornmann, O., Dahl, R., Centanni, S., Dogra, A., Owen, R. J., Lassen, C., & Krämer, B. (2010) · European Respiratory Journal · doi:10.1183/09031936.00045810 · Cited by 212
Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort study
Duong, M., Islam, S., Rangarajan, S., Leong, D. P., Kurmi, O., Teo, K. K., Killian, K. J., Dagenais, G. R., Lear, S. A., Wielgosz, A. T., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30070-1 · Cited by 209
Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study
Meghji, J. Z., Lesosky, M., Joekes, E. C., Banda, N. P. K., Rylance, J., Gordon, S. B., Jacob, J., Zonderland, H. M., MacPherson, P., Corbett, E. L., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2019-213808 · Cited by 209
Acute Exacerbations of COPD in the United States: Inpatient Burden and Predictors of Costs and Mortality
Perera, P. N., Armstrong, E. P., Sherrill, D. L., & Skrepnek, G. H. (2012) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2011.650239 · Cited by 205
Symptoms, Comorbidities, and Health Care in Advanced Chronic Obstructive Pulmonary Disease or Chronic Heart Failure
Janssen, D. J. A., Spruit, M. A., Uszko‐Lencer, N. H. M. K., Schols, J. M. G. A., & Wouters, E. F. �. (2011) · Journal of Palliative Medicine · doi:10.1089/jpm.2010.0479 · Cited by 194
COPD and stroke: are systemic inflammation and oxidative stress the missing links?
Austin, V., Crack, P. J., Bozinovski, S., Miller, A. A., & Vlahos, R. (2016) · Clinical Science · doi:10.1042/cs20160043 · Cited by 193
Sex Differences in Mortality and Clinical Expressions of Patients with Chronic Obstructive Pulmonary Disease: The TORCH Experience
Celli, B. R., Vestbo, J., Jenkins, C. R., Jones, P., Ferguson, G. T., Calverley, P. M. A., Yates, J., Anderson, J. A., Willits, L. R., & Wise, R. A. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201004-0665oc · Cited by 191
COPD and Cardiovascular Disease
André, S., Conde, B., Fragoso, E., Boléo-Tomé, J. P., Areias, V., Cardoso, J., & Crónica, O. B. O. T. G. D.-G. D. I. N. D. P. O. (2018) · Pulmonology · doi:10.1016/j.pulmoe.2018.09.006 · Cited by 205
The global burden of COPD: epidemiology and effect of prevention strategies
de, M. M., Pérez‐Padilla, R., Celli, B. R., Aaron, S. D., Wehrmeister, F. C., Amaral, A. F. S., Mannino, D. M., Zheng, J., Salvi, S. S., Obaseki, D., et al. (2025) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(24)00339-4 · Cited by 214
Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies
Chan, S. M. H., Selemidis, S., Bozinovski, S., & Vlahos, R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.013 · Cited by 186
The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD ( GOLD ) – why and what?
Vestbo, J., Hurd, S. S., & Rodriguez‐Roisin, R. (2012) · The Clinical Respiratory Journal · doi:10.1111/crj.12002 · Cited by 176
Emphysema Scores Predict Death From COPD and Lung Cancer
Zulueta, J. J., Wisnivesky, J. P., Henschke, C. I., Yip, R., Farooqi, A. O., McCauley, D. I., Chen, M., Libby, D. M., Smith, J. P., Pasmantier, M. W., et al. (2011) · CHEST Journal · doi:10.1378/chest.11-0101 · Cited by 172
Leitlinie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD)
Vogelmeier, C. F., Buhl, R., Burghuber, O. C., Criée, C.-P., Ewig, S., Godnić‐Cvar, J., Hartl, S., Herth, F. J. F., Kardos, P., Kenn, K., et al. (2018) · Pneumologie · doi:10.1055/s-0043-125031 · Cited by 185
The Obesity Paradox in Patients With Peripheral Arterial Disease
Galal, W., van Gestel, Y. R. B. M., Hoeks, S. E., Sin, D. D., Winkel, T. A., Bax, J. J., Verhagen, H., Awara, A. M. M., Klein, J., van Domburg, R. T., et al. (2008) · Chest · doi:10.1378/chest.08-0418 · Cited by 159
Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease. Development and Validation of the COPD Lung Cancer Screening Score
de-Torres, J. P., Wilson, D. O., Sánchez-Salcedo, P., Weissfeld, J. L., Bertó, J., Campo, A., Alcaide, A. B., García‐Granero, M., Celli, B. R., & Zulueta, J. J. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201407-1210oc · Cited by 154
Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease
Høiseth, A. D., Neukamm, A. M. C., Karlsson, B. D., Omland, T., Brekke, P., & Søyseth, V. (2011) · Thorax · doi:10.1136/thx.2010.153122 · Cited by 154
Early detection of COPD is important for lung cancer surveillance
Sekine, Y., Katsura, H., Koh, E., Hiroshima, K., & Fujisawa, T. (2011) · European Respiratory Journal · doi:10.1183/09031936.00126011 · Cited by 147
Sex differences in mortality in patients with COPD
de-Torres, J. P., Côté, C., López, M. V., Casanova, C., Orlando Díaz, P., Marín, J. M., Pinto-Plata, V., de Oca, M. M., Nekach, H., Dordelly, L. J., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00096108 · Cited by 139
Advance care planning in COPD
Patel, K. B., Janssen, D. J. A., & Curtis, J. R. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.02087.x · Cited by 139
Chronic Obstructive Pulmonary Disease: A Chronic Systemic Inflammatory Disease
van Eeden, S. F., & Sin, D. D. (2007) · Respiration · doi:10.1159/000111820 · Cited by 138
Chronic obstructive pulmonary disease and cerebrovascular disease: A comprehensive review
Lahousse, L., Tiemeier, H. W., Ikram, M. A., & Brusselle, G. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.07.014 · Cited by 140
A Postmortem Analysis of Major Causes of Early Death in Patients Hospitalized With COPD Exacerbation
Zvezdin, B., Milutinov, S., Vukoja, M. K., Hadnadjev, M., Hromiš, S., Marković, M., & Gajic, O. (2009) · CHEST Journal · doi:10.1378/chest.08-2918 · Cited by 136
Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional study
García-Olmos, L., Alberquilla, Á., Ayala, V., García-Sagredo, P., Morales, L., Carmona, M., de Tena-Dávila, M. J., Carrasco, M., Carrero, A. M., Salvador, C. H., et al. (2013) · BMC Family Practice · doi:10.1186/1471-2296-14-11 · Cited by 140
MicroRNA Profiling Reveals a Role for MicroRNA-218-5p in the Pathogenesis of Chronic Obstructive Pulmonary Disease
Conickx, G., Mestdagh, P., Cobos, F. A., Verhamme, F. M., Maes, T., Vanaudenaerde, B. M., Seys, L., Lahousse, L., Kim, R., Hsu, A., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1182oc · Cited by 134
Sex-related differences in COPD in five Latin American cities: the PLATINO study
Varela, M. V. L., de, M. M., Halbert, R. J., Muiño, A., Pérez‐Padilla, R., Tálamo, C., Jardim, J. R., Valdivia, G. G., Pertuzé, J., Moreno, D., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00165409 · Cited by 134
Web-based Health Information Seeking and eHealth Literacy among Patients Living with Chronic Obstructive Pulmonary Disease (COPD)
Stellefson, M., Shuster, J. J., Chaney, B. H., Paige, S. R., Alber, J. M., Chaney, J. D., & Sriram, P. (2017) · Health Communication · doi:10.1080/10410236.2017.1353868 · Cited by 140
Efficacy of multiparametric telemonitoring on respiratory outcomes in elderly people with COPD: a randomized controlled trial
Pedone, C., Chiurco, D., Scarlata, S., & Incalzi, R. A. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-82 · Cited by 135
Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease
Baghai-Ravary, R., Quint, J. K., Goldring, J. J. P., Hurst, J. R., Donaldson, G. C., & Wedzicha, J. A. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.09.022 · Cited by 133
Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations
Glaab, T., Vogelmeier, C., & Buhl, R. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-79 · Cited by 130
Effect of blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records
Quint, J. K., Herrett, E. L., Bhaskaran, K., Timmis, A., Hemingway, H., Wedzicha, J. A., & Smeeth, L. L. (2013) · BMJ · doi:10.1136/bmj.f6650 · Cited by 126
An Official American Thoracic Society Workshop Report: The Integrated Care of the COPD Patient
Nici, L. L., & ZuWallack, R. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201201-014st · Cited by 133
Two Distinct Chronic Obstructive Pulmonary Disease (COPD) Phenotypes Are Associated with High Risk of Mortality
Burgel, P., Paillasseur, J.-L., Peene, B., Dusser, D. J., Roche, N., Coolen, J., Troosters, T., Decramer, M., & Janssens, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051048 · Cited by 128
Echocardiographic evaluation of heart in chronic obstructive pulmonary disease patient and its co-relation with the severity of disease
Agrawal, R., Gupta, N., Srivastav, A., & Ved, M. (2011) · Lung India · doi:10.4103/0970-2113.80321 · Cited by 124
Statins, systemic inflammation and risk of death in COPD: The Rotterdam study
Lahousse, L., Loth, D. W., Joos, G., Albert Hofman, D., Leufkens, H. G. M., Brusselle, G., & Stricker, B. H. C. (2012) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2012.10.008 · Cited by 124
Asthma and comorbid medical illness
Cazzola, M., Calzetta, L., Bettoncelli, G., Novelli, L., Cricelli, C. A., & Rogliani, P. (2010) · European Respiratory Journal · doi:10.1183/09031936.00140310 · Cited by 123
Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease
MacNee, W. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.732703 · Cited by 123
Towards integration of palliative care in patients with chronic heart failure and chronic obstructive pulmonary disease: a systematic literature review of European guidelines and pathways
Siouta, N., Beek, K. V., Preston, N. J., Hasselaar, J. G. J., Hughes, S. P. F., Payne, S. A., Garralda, E., Centeno, C., der Eerden, M. D. H.-V., Groot, M. M., et al. (2016) · BMC Palliative Care · doi:10.1186/s12904-016-0089-4 · Cited by 123
Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis
Rothnie, K., Yan, R., Smeeth, L. L., & Quint, J. K. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007824 · Cited by 126
Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study
Almagro, P., Garcı́a, F. L., Cabrera, F. J., Montero, L., Morchón, D., Díez‐Manglano, J., & Soriano, J. B. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.09.019 · Cited by 122
The Projected Epidemic of Chronic Obstructive Pulmonary Disease Hospitalizations over the Next 15 Years. A Population-based Perspective
Khakban, A., Sin, D. D., FitzGerald, J. M., McManus, B. M., Ng, R. T., Hollander, Z., & Sadatsafavi, M. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201606-1162pp · Cited by 121
Recommendations for epidemiological studies on COPD
Bakke, P. S., Rönmark, E., Eagan, T., Pistelli, F., Annesi‐Maesano, I., Maly, M., Meren, M., Vermeire, P. A., Vestbo, J., Viegi, G., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00193809 · Cited by 124
Role of clinical frailty on long-term mortality of elderly subjects with and without chronic obstructive pulmonary disease
Galizia, G., Cacciatore, F., Testa, G., Della‐Morte, D., Mazzella, F., Langellotto, A., Raucci, C., Gargiulo, G., Ferrara, N., Rengo, F., et al. (2011) · Aging Clinical and Experimental Research · doi:10.1007/bf03351076 · Cited by 120
Underdiagnosis of myocardial infarction in COPD – Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation
Brekke, P., Omland, T., Smith, P., & Søyseth, V. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.04.010 · Cited by 115
Hypercapnia Impairs Lung Neutrophil Function and Increases Mortality in Murine Pseudomonas Pneumonia
Gates, K. L., Howell, H. A., Nair, A., Vohwinkel, C. U., Welch, L. C., Beitel, G. J., Hauser, A. R., Sznajder, J. I., & Sporn, P. H. S. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0487oc · Cited by 115
Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance
Stevenson, C. S., & Birrell, M. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.10.008 · Cited by 118
Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease.
van Remoortel, H., Hornikx, M., Langer, D., Burtin, C., Everaerts, S., Verhamme, P., Boonen, S., Gosselink, R., Decramer, M., Troosters, T., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201307-1240oc · Cited by 122
Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities
Bernardo, I., Bozinovski, S., & Vlahos, R. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.08.005 · Cited by 108
Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study
de Luise, C., Brimacombe, M. B., Pedersen, L. H., & Sørensen, H. T. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9211-5 · Cited by 105
Multicomponent indices to predict survival in COPD: the COCOMICS study
Marín, J. M., Alfageme, I., Almagro, P., Casanova, C., Esteban, C., Soler‐Cataluña, J. J., de-Torres, J. P., Martínez‐Camblor, P., Miravitlles, M., Celli, B. R., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00121012 · Cited by 104
Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients
Dutro, M. P., Make, Paulose-Ram, Marton, J. P., Mapel, D. W., Make, B. J., & Paulose‐Ram, R. (2012) · International Journal of COPD · doi:10.2147/copd.s27032 · Cited by 102
Lung volume reduction surgery for diffuse emphysema
Tiong, L. U., Gibson, P. G., Hensley, M., Hepworth, R., Lasserson, T. J., Smith, B., & Davies, H. R. H. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001001.pub2 · Cited by 101

Authors: Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G.
Affiliations: St. Paul's Hospital (CA)
London School of Hygiene & Tropical Medicine (GB)
ORCID: Sin, D. D.
Soriano, J. B.
Venue: European Respiratory Journal
Publisher: European Respiratory Society (ERS)
Published: 2006-11-30
Volume: 28
Issue: 6
Pages: 1245-1257
ISSN: 0903-1936 (ISSN-L)
1399-3003
DOI: 10.1183/09031936.00133805
OpenAlex: W2118228748
Cited by: 1,052
References: 142
Citations by year: 2026: 22 · 2025: 44 · 2024: 43 · 2023: 40 · 2022: 36 · 2021: 60 · 2020: 61 · 2019: 55 · 2018: 61 · 2017: 63 · 2016: 76 · 2015: 61 · 2014: 77 · 2013: 74 · 2012: 51
FWCI: 7.69
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: European Respiratory Journal (publishedVersion)
PubMed (publishedVersion)
Funders: AstraZeneca
GlaxoSmithKline
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Keywords: chronic obstructive pulmonary disease, COPD mortality, comorbidities, cardiovascular disease, lung cancer, low-grade inflammation, respiratory failure, FEV1, BODE index, St George's Respiratory Questionnaire, mortality prediction, health assessment
MeSH terms: Health Status, Humans, Comorbidity, Pulmonary Disease, Chronic Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mortality in COPD: role of comorbidities

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks